Annual Non Current Assets
$5.72 M
+$171.00 K+3.08%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual long term assets is $5.72 million, with the most recent change of +$171.00 thousand (+3.08%) on December 31, 2023.
- During the last 3 years, ELVN annual non current assets has risen by +$5.30 million (+1274.04%).
- ELVN annual non current assets is now at all-time high.
Performance
ELVN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$8.43 M
-$483.00 K-5.42%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly long term assets is $8.43 million, with the most recent change of -$483.00 thousand (-5.42%) on September 30, 2024.
- Over the past year, ELVN quarterly non current assets has increased by +$2.85 million (+51.18%).
- ELVN quarterly non current assets is now -5.42% below its all-time high of $8.92 million, reached on June 30, 2024.
Performance
ELVN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ELVN Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | +51.2% |
| 3 y3 years | +1274.0% | +73.4% |
| 5 y5 years | +1274.0% | +73.4% |
ELVN Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.0% | -5.4% | +228.6% |
| 5 y | 5-year | at high | +1274.0% | -5.4% | +228.6% |
| alltime | all time | at high | +1274.0% | -5.4% | +228.6% |
Enliven Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.43 M(-5.4%) |
| Jun 2024 | - | $8.92 M(+59.8%) |
| Mar 2024 | - | $5.58 M(-2.4%) |
| Dec 2023 | $266.15 M | $5.72 M(+5.2%) |
| Sep 2023 | - | $5.43 M(+2.0%) |
| Jun 2023 | - | $5.33 M(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.86 M(-12.3%) |
| Dec 2022 | $77.75 M(-29.7%) | $5.54 M(+116.1%) |
| Sep 2022 | - | $2.57 M(-3.5%) |
| Dec 2021 | $110.67 M(-15.3%) | - |
| Dec 2021 | - | $2.66 M |
| Dec 2020 | $130.59 M | - |
FAQ
- What is Enliven Therapeutics annual long term assets?
- What is the all time high annual non current assets for Enliven Therapeutics?
- What is Enliven Therapeutics annual non current assets year-on-year change?
- What is Enliven Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly non current assets year-on-year change?
What is Enliven Therapeutics annual long term assets?
The current annual non current assets of ELVN is $5.72 M
What is the all time high annual non current assets for Enliven Therapeutics?
Enliven Therapeutics all-time high annual long term assets is $5.72 M
What is Enliven Therapeutics annual non current assets year-on-year change?
Over the past year, ELVN annual long term assets has changed by +$171.00 K (+3.08%)
What is Enliven Therapeutics quarterly long term assets?
The current quarterly non current assets of ELVN is $8.43 M
What is the all time high quarterly non current assets for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly long term assets is $8.92 M
What is Enliven Therapeutics quarterly non current assets year-on-year change?
Over the past year, ELVN quarterly long term assets has changed by +$2.85 M (+51.18%)